| UHC Commercial Medical & Drug | Sacroiliac Joint Interventions - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Sensory Integration Therapy and Auditory Integration Training - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Sinus Surgeries and Interventions - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Sleep Studies - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Sodium Hyaluronate - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Spinal Fusion and Bone Healing Enhancement Products - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Spinal Fusion and Decompression - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Spinraza® (Nusinersen) - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Subcutaneous Implantable Naltrexone Pellets - Commercial Medical Benefit Drug Policy | 2026-01-01 |